بِسْمِ اللَّهِ الرَّحْمَٰنِ الرَّحِيمِ
15 Jumada al-Ula 1448 AH
Fajr: 04:36 Dhuhr: 11:58 Asr: 15:12 Maghrib: 18:02 Isha: 19:11
☪
فَاسْأَلُوا أَهْلَ الذِّكْرِ
Islamic Fiqh & Jurisprudence

Islamic Scholar Clarifies Rulings on Employment in the Pharmaceutical Industry Under Hanafi Jurisprudence

By: Nana Muazin • Sep 29, 2026 • 5 min read

By a Special Correspondent

In response to growing queries from Muslim professionals navigating modern corporate careers, prominent Islamic scholar Shaykh Faraz Rabbani has issued a comprehensive clarification confirming that employment within the pharmaceutical industry is generally permissible under the Hanafi school of Islamic jurisprudence.

The ruling, which addresses anxieties regarding medicines containing ingredients such as porcine gelatin and glycerol, assures professionals that their earnings are lawful and that their conscientious pursuit of halal income is commendable.

The clarification was prompted by questions from individuals who perceived apparent contradictions in previous legal opinions regarding employment in various science-backed sectors. Addressing these concerns, Shaykh Rabbani explained that the production of medicine fundamentally aligns with prophetic traditions encouraging the pursuit of healing. He cited an authentic narration from Sahih al-Bukhari in which the Prophet Muhammad, peace and blessings be upon him, stated, "Allah has sent down no illness without also sending down a cure for it."

Evaluating Corporate Ethics and Income Sources

To determine whether a specific job is permissible, Islamic jurisprudence applies consistent foundational tests regarding a company’s predominant source of income and whether an individual’s specific role constitutes direct assistance in a prohibited act.

According to classical Hanafi texts, mixed corporate wealth is evaluated by examining what predominates within the business operations. Referencing the authoritative legal compendium al-Fatawa al-Hindiyya, Shaykh Rabbani noted that if the majority of a business’s revenue and wealth is lawful, there is generally no legal barrier to benefiting from financial dealings or employment associated with it, provided the worker is not directly engaged in unlawful activities.

The scholar contrasted this with previous rulings concerning other industries, such as a hair-restoration business that failed foundational compliance tests because its primary product—wigs made of real human hair—is explicitly forbidden for sale under the Hanafi school. In contrast, laboratory equipment suppliers and standard pharmaceutical developers pass these preliminary tests, provided their operational focus remains on lawful healthcare solutions. Furthermore, administrative or support roles, such as help-desk operations within these compliant firms, do not constitute direct participation in any religious transgression.

The Status of Medicinal Ingredients and Transformation

A central concern for many Muslim scientists and researchers involves the presence of animal-derived components, such as porcine gelatin or glycerol, in certain medical formulations. However, the scholar emphasized that the inclusion of such components does not automatically render the entire pharmaceutical product unlawful.

Within the Hanafi school, a chemical or physical process known as istihala—complete transformation—plays a critical role in changing the legal status of a substance. When an impermissible ingredient undergoes manufacturing processes that fundamentally alter its chemical essence, it receives a new legal ruling because its original properties have ceased to exist.

Shaykh Rabbani cited the renowned jurist Ibn Abidin, who referenced Fath al-Qadir in his seminal work Radd al-Muhtar to explain that the complete transformation of a substance removes the legal prohibitions previously tied to its original form.

Furthermore, even in scenarios where an impermissible ingredient is not fully transformed and remains present in a medical product, classical jurisprudence accommodates necessity and public health. Citing the legal text al-Durr al-Mukhtar by the jurist Haskafi, the ruling highlights that the medicinal use of such compounds is permitted when a cure is established, and no alternative remedy is available. This application parallels established legal exceptions in Islamic law, such as the temporary allowance of prohibited substances under conditions of dire necessity, forming the basis of contemporary fatwas on the matter.

Employee Responsibilities and Professional Roles

Addressing the practicalities of modern employment, the scholar stressed that professionals are not required to conduct exhaustive audits of their employers’ entire supply chains or internal revenue structures, provided the enterprise is fundamentally engaged in lawful commerce. Citing al-Fatawa al-Hindiyya, the guidance affirms that an individual may engage with an entity whose wealth is predominantly lawful "as long as it has not become clear to him that it is unlawful."

Pharmaceutical companies do not derive their primary revenue from prohibited goods; rather, their core business centers on healthcare, research, and pharmacology. Consequently, professionals working in specialized departments—including research and development, clinical trials, regulatory affairs, and project management—are fully permitted to carry out their duties, even if their projects occasionally touch upon lines containing contested excipients.

Shaykh Rabbani advised that employees should avoid acting as the direct agents of clearly prohibited acts, and where they hold professional influence, they should advocate for alternative, plant-based, or halal-certified excipients, such as vegetable-derived capsules.

The guidance concludes by framing the healing arts within a spiritual context, referencing Quranic verses that encourage mutual cooperation in righteousness and piety while prohibiting cooperation in sin and transgression. Assisting in the development of treatments that alleviate human suffering is characterized as an act of profound social good, allowing professionals to approach their daily work in clinical research and pharmaceutical development with peace of mind and sincere intention.

☪
Author / Editorial Team:

Nana Muazin